Zemin Xiao
Changde, 415000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Development and validation of a machine learning model to preoperatively predict very early recurrence in patients with hepatitis B virus-related hepatocellular carcinoma.
Journal: Scientific reports
Published: April 17, 2026
Geographic disparities and health inequality evolution in the disease burden of tracheal, bronchus, and lung cancer in Asia: a 33-year longitudinal analysis and future projections.
Journal: Annals of medicine
Published: February 03, 2026
Prognostic value of combined FIB-4 and AFP in predicting survival after hepatectomy for hepatocellular carcinoma: a multicenter cohort study.
Journal: BMC cancer
Published: January 19, 2026
Severe skin toxicity and early progression following neoadjuvant ensartinib and surgery in anaplastic lymphoma kinase-positive locally advanced lung cancer: a case report.
Journal: Frontiers in pharmacology
Published: July 25, 2025
Dosimetric evaluation of image-guided adaptive radiotherapy for locally advanced cervical cancer.
Journal: Medicine
Published: April 28, 2025
Long-term survival in advanced pulmonary large-cell neuroendocrine carcinoma after multi-line immunochemotherapy and anti-angiogenic therapy: a case report.
Journal: Frontiers in immunology
Published: April 26, 2025
Dosimetric evaluation of simplified intensity-modulated radiation therapy for thoracic tumors.
Journal: Medicine
Published: February 28, 2025
The molecular characteristics of DNA damage and repair related to P53 mutation for predicting the recurrence and immunotherapy response in hepatocellular carcinoma.
Journal: Scientific reports
Published: January 31, 2025
Mitochondrial gene SLC25A24 regulated anti-tumor immunity and inhibited the proliferation and metastasis of colorectal cancer by PKG1-dependent cGMP/PKG1 pathway.
Journal: International immunopharmacology
Published: January 29, 2025
QKI-induced circ_0001766 inhibits colorectal cancer progression and rapamycin resistance by miR-1203/PPP1R3C/mTOR/Myc axis.
Journal: Cell death discovery
Published: November 13, 2024
Anlotinib Plus Docetaxel is Promising in Advanced NSCLC Progressing on First-Line Immunotherapy: A Pooled Analysis of Two Randomized Trials.
Journal: Advances in therapy
Published: October 31, 2024
Last Updated: 09/26/2026